C-2HKJeGenesis
genome engineering, xenotransplantation, transplantation
replacementreplacinggene editing
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-2HKJ
C-2HKJC-2HKJgenome engineering, xenotransplantation, transplantation
0-100 chain-logic scale · 15 dimensions · scored on public evidence
eGenesis genome engineering, xenotransplantation, transplantation
eGenesis is working at the intersection of genome engineering and transplantation to advance human-compatible organs for patients with organ failure. Its platform uses three classes of edits intended to address organ safety and efficacy. The company highlights kidney, liver, and heart transplant programs and notes FDA IND clearance for EGEN-2784, a genetically engineered porcine-derived kidney.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
eGenesis — Translational · Bottom quartile. Derived deterministically from 10 extracted project(s). Most-advanced status: phase 1. Band: translational. Modifiers: +5 depth (4 programs at…
Source: Deterministic